Introduction
The European Renal Association -European Dialysis and Transplant Association (ERA-EDTA) Registry's annual report describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) within Europe and adjacent countries based on data collected via the national and regional renal registries [1] . On an annual basis, we publish a summary of the ERA-EDTA Registry's annual report that is intended to provide the reader with an overview of the current status of RRT for ESRD in Europe [2] [3] [4] . In 2016, we received the 2014 data from 51 national or regional renal registries in 35 countries covering a general population of 531.7 million people. This represented 65.4% of the 2014 European general population. Thirty-two national or regional renal registries from 17 countries provided individual patient data, whereas 19 countries or regions provided aggregated data (see Appendix 1). The proportion of the European population covered by the ERA-EDTA Registry in 2014 was lower than that of 2013 (73.6%) due to the absence of Russia and Slovenia from this year's annual report. This summary presents the 2014 incidence and prevalence of patients receiving RRT, kidney transplantation activity and the patient and graft survival in these 35 countries. The methods used to derive the results presented in this overview, along with the full results, can be found in the ERA-EDTA Registry 2014 Annual Report [1] .
Incidence of RRT
In 2014, 70 953 individuals commenced RRT for ESRD, which equated to an overall unadjusted incidence rate of 133 per million population (pmp, Table 1 ). The unadjusted incidence rate was highest in Portugal (237 pmp), Greece (218 pmp) and Cyprus (204 pmp), whereas it was lowest in the Ukraine (23 pmp) and Iceland (58 pmp, Table 1 and Figures 1 and 2 ). Of the patients commencing RRT, the majority were men (63%), over half were aged 65 years (55%) and a quarter had diabetes mellitus (26%) as their primary renal diagnosis ( Figure 3 ). The mean age of the patients commencing RRT in all countries and regions combined was 64.6 years (Table 1) . However, this ranged from a mean age of 55.1 years in Albania to 70.1 years in Dutchspeaking Belgium. Of the incident patients alive and receiving RRT at day 91 after the start of treatment, the majority were receiving haemodialysis (81%), 13% were receiving peritoneal dialysis and 6% were living with a kidney transplant (Figure 4) . However, the modality of RRT at day 91 after the start of treatment varied considerably between age groups; as the age of the patient increased the proportion of patients receiving either peritoneal dialysis or living with a kidney transplant decreased. Furthermore, patients with a primary renal diagnosis of diabetes mellitus were half as likely to have a kidney transplant by day 91 compared with the non-diabetic group (3% versus 7%).
Prevalence of RRT
On 31 December 2014, 490 743 individuals were receiving RRT for ESRD (Table 2) . This equated to an unadjusted prevalence of 924 pmp. Again there was considerable variation between countries, with the highest unadjusted prevalence rates seen in Portugal (1794 pmp), the Spanish regions of Catalonia (1312 pmp), Valencia (1298 pmp), Galicia (1265 pmp) and Murcia (1258 Table 1 . Incidence of RRT in 2014 at day 1, for all primary renal diseases combined and diabetes mellitus types 1 and 2, by count (N) and unadjusted rate per million population, and for all primary renal diseases combined, the mean age at the start of RRT, presented by country/ region Patients younger than 20 years of age are not reported. The true incidence counts are, therefore, slightly higher than the counts reported here. pmp), and French-and Dutch-speaking Belgium (1250 pmp and 1238 pmp, respectively, Table 2 and Figures 5 and 6 ). The unadjusted prevalence of RRT was considerably lower in the Ukraine (157 pmp) and Albania (374 pmp). Of the prevalent patients, the majority were men (60%); however, now just under half were aged 65 years (44%) and a fifth had diabetes mellitus (19%) as their primary renal diagnosis ( Figure 7 ). The mean age of the prevalent patients receiving RRT in all countries and regions combined was 60.9 years ( Table 2 ). This ranged from a mean age of 51.4 years in Albania to 66.4 years in Portugal. The majority of prevalent patients were receiving haemodialysis (57%), just over a third of patients were living with a kidney transplant (37%) and only 5% were receiving peritoneal dialysis ( Figure 8 ). Once again the modality of RRT varied considerably between age groups; as the age of the prevalent patients increased the proportion living with a kidney transplant decreased. For those aged 20-44 years, 65% were living with a kidney transplant, whereas this was only 40% of patients aged 65-74 years. Again prevalent patients with a primary renal diagnosis of diabetes mellitus were much less likely to be living with a kidney transplant compared with the non-diabetic group (28% versus 49%).
Kidney transplantation
In 2014, 19 406 kidney transplantations were performed that equated to an overall unadjusted transplant rate of 36 pmp ( Figure 9 ). Again this figure varied considerably between countries with the highest unadjusted transplant rates seen in the Netherlands (59 pmp), Spain (57 pmp) and Norway (53 pmp), with some Spanish regions reaching even higher rates. Conversely, the lowest unadjusted transplant rates were reported in the Ukraine (2 pmp), Georgia (6 pmp) and Bulgaria (7 pmp). Overall the unadjusted deceased donor transplant rate was more than double that of the unadjusted living donor transplant rate (27 pmp versus 12 pmp, Figure 10 ; 68% versus 31%, Figure 11 ). The highest unadjusted rates of deceased donor transplants were seen in Spain (48 pmp), Croatia (46 pmp) and the Czech Republic (43 pmp, Figure 10 ), whereas the highest unadjusted rate of living donor transplants were seen in the Netherlands (31 pmp), Turkey (30 pmp) and Northern Ireland (28 pmp, Figure 10 ).
Survival of patients receiving RRT
For patients commencing RRT in the period 2005-09, the 1-, 2-and 5-year-adjusted patient survival probabilities on all RRT modalities were 90.0% [95% confidence interval (CI) 89.9-90.2], 82.8% (95% CI 82.6-83.0) and 63.3% (95% CI 63.0-63.6), respectively (see Appendix 2 and Table 3 
Expected remaining lifetime
There remains a substantial difference in the expected remaining lifetime between the general population and those receiving dialysis (Figure 13 ). Patients aged 20-45 years old The overall prevalence of RRT is underestimated by approximately 3% due to an estimated 30% underreporting of patients living on a functioning graft. e Data on the prevalence of cause of renal failure (DM) are based on 8897 of 71 318 patients (12.5%).
receiving dialysis are expected to live only one-third as long as the age-matched general population. The prospect is even worse for patients aged 55-64 years, as they are expected to live only a quarter as long as their age-matched counterparts in the general population. Patients living with a kidney transplant fare better than their counterparts receiving dialysis. However, for the transplant recipients aged 20-49 years their life expectancy is still approximately one-third less than that of the age-matched general population. As the age of the transplant recipient increases, the disparity in life Northern Ireland and Wales. The total count for Austria is based on residents and non-residents. For Romania, the transplantation activity reflects 70% of the total transplantation activity in the country due to an underreporting of pre-emptive transplantation. Analyses were adjusted using fixed values: age (45 years), gender (60% men) and primary renal disease (10% diabetes mellitus, 8% hypertension/renal vascular disease, 28% glomerulonephritis and 54% other causes).
